Literature DB >> 3041042

Frequent segregation of more-defective variants from a Rous sarcoma virus packaging mutant, TK15.

M Nishizawa, T Koyama, S Kawai.   

Abstract

TK15, a mutant derived from a temperature-sensitive mutant of Rous sarcoma virus (tsNY68), has extremely low infectivity although it has intact viral genes. Previous analyses of the virus and virus-induced transformants showed that the mutant has a defect in packaging of its own genomic RNA, possibly owing to a deletion near the 5' end. Another striking feature of TK15 is that it induces various types of virus-nonproducing (NP) transformants, 15c(-), at high frequency. In this work, the mechanisms of frequent segregation of NP cells were examined by molecular cloning of TK15-derived proviruses from NP cell clones and their sequence analysis. The structure of the major type of provirus, found in about half of the NP cell clones, was colinear with src subgenomic mRNA and was suggested to be due to infection with virions containing subgenomic mRNA in place of genomic RNA. Other types of proviruses present in 15c(-) cells appeared to contain cellular sequences of various lengths replacing various parts of viral sequences. The mechanism for the generation of these proviruses is discussed in relation to the nature of the packaging mutant.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3041042      PMCID: PMC255899          DOI: 10.1128/JVI.61.10.3208-3213.1987

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

1.  Microinjection analysis of envelope-glycoprotein messenger activities of avian leukosis viral RNAs.

Authors:  D W Stacey; V G Allfrey; H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1977-04       Impact factor: 11.205

2.  In vitro packaging of lambda Dam vectors and their use in cloning DNA fragments.

Authors:  L Enquist; N Sternberg
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

Review 3.  The mechanism for genetic recombination in the avian retroviruses.

Authors:  E Hunter
Journal:  Curr Top Microbiol Immunol       Date:  1978       Impact factor: 4.291

Review 4.  Retroviruses.

Authors:  J M Bishop
Journal:  Annu Rev Biochem       Date:  1978       Impact factor: 23.643

5.  Genetically stable reassortment of markers during mixed infection with avian tumor viruses.

Authors:  P K Vogt
Journal:  Virology       Date:  1971-12       Impact factor: 3.616

6.  Genetic recombination with avian tumor virus.

Authors:  S Kawai; H Hanafusa
Journal:  Virology       Date:  1972-07       Impact factor: 3.616

7.  The effects of reciprocal changes in temperature on the transformed state of cells infected with a rous sarcoma virus mutant.

Authors:  S Kawai; H Hanafusa
Journal:  Virology       Date:  1971-11       Impact factor: 3.616

8.  Preparative and analytical purification of DNA from agarose.

Authors:  B Vogelstein; D Gillespie
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

9.  Recombination between a temperature-sensitive mutant and a deletion mutant of Rous sarcoma virus.

Authors:  S Kawai; H Hanafusa
Journal:  J Virol       Date:  1976-08       Impact factor: 5.103

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  3 in total

1.  Characterization of unintegrated retroviral DNA with long terminal repeat-associated cell-derived inserts.

Authors:  M M Dunn; J C Olsen; R Swanstrom
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

2.  The LTR, v-src, LTR provirus generated in the mammalian genome by src mRNA reverse transcription and integration.

Authors:  J Bodor; J Svoboda
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

3.  Packaging of human immunodeficiency virus type 1 RNA requires cis-acting sequences outside the 5' leader region.

Authors:  J H Richardson; L A Child; A M Lever
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.